Literature DB >> 12768076

Azathioprine hypersensitivity: report of two cases and review of the literature.

Renato A Sinico1, Ettore Sabadini, Sabrina Borlandelli, Pablo Cosci, Luca Di Toma, Enrico Imbasciati.   

Abstract

Azathioprine (AZA) is a widely-used drug in the treatment of different diseases such as vasculitis, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel diseases and in renal transplantation. Side effects of AZA can be classified as toxic, mainly dose related (myelosuppression and hepatotoxicity) and idiosyncratic, mainly dose independent. While the toxic effects are common and well documented, the hypersensitivity reactions are rare and it is not often easy to distinguish them from systemic sepsis or disease recurrence. We report two cases of AZA hypersensitivity occurring in patients with anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis each mimicking a vasculitis relapse or a septic complication of immunosuppression, as well as a review of the literature.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12768076

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  2 in total

Review 1.  Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel Disease.

Authors:  H Matthew Cohn; Maneesh Dave; Edward V Loftus
Journal:  Inflamm Bowel Dis       Date:  2017-08       Impact factor: 5.325

Review 2.  EPONYM. Sweet syndrome.

Authors:  Mi Jin Kim; Yon Ho Choe
Journal:  Eur J Pediatr       Date:  2010-05-06       Impact factor: 3.860

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.